Aug 12, 2020

ThermoGenesis Holdings To Delay Second Quarter 2020 Earnings

Bizclik Editor
1 min

RANCHO CORDOVA, Calif., Aug. 11, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced it will delay its second quarter earnings release and conference call for the quarter ended June 30, 2020, previously scheduled for Wednesday, August 12, 2020. The Company now intends to report its second quarter 2020 results on Friday, August 14, 2020, after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET.

To participate in the conference call, please dial 1-844-889-4331 (domestic), 1-412-380-7406 (international) or 1-866-605-3852 (Canada). To access a live webcast of the call, please visit:

A webcast replay will be available on ThermoGenesis' website for three months by visiting the Investor page of the Company's website at

About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit:

Company Contact: 
Wendy Samford
[email protected]

Investor Contact: 
Paula Schwartz, Rx Communications
[email protected]


Cision View original content:

SOURCE ThermoGenesis Holdings, Inc.

Share article

Subscribe to our Newsletter
Receive the latest updates and news
Exclusive preview